Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the date of June 13, 2022

 

Commission File Number 001-39124

 

Centogene N.V.
(Translation of registrant's name into English)

 

Am Strande 7
18055 Rostock

Germany
(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F..X.. Form 40-F.....

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ____

 

 

 

Centogene N.V.

 

On June 13, 2022, Centogene N.V. issued a press release titled “CENTOGENE and Agios Expand Partnership for Clinical Development of PYRUKYND^® (mitapivat) to Treat Children With Rare Blood Disease”.

 

Such materials are attached as exhibits to this Form 6-K and are incorporated by reference herein.

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: June 13, 2022

 

	CENTOGENE N.V.
	By:	/s/ Miguel Coego Rios
		Name:	Miguel Coego Rios
		Title:	EVP Finance & Legal and Interim CFO

 

 

Exhibit Index

 

Exhibit	Description of Exhibit
99.1	Announcement dated June 13, 2022